SYDNEY, Monday 12 December 2016

Cellmid Limited (ASX: CDY) provides this update to shareholders on recent developments regarding its midkine diagnostic license to Pacific Edge Biotechnology Limited (Pacific Edge).

Pacific Edge announced the achievement of a number of material milestones in recent months, which are expected to positively influence future royalty payments.

Click here to